GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427104. A total of 2 filers reported holding GENOCEA BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $13,000 | +44.4% | 5,753 | +11.6% | 0.01% | +20.0% |
Q1 2020 | $9,000 | -40.0% | 5,153 | +3.1% | 0.01% | -28.6% |
Q3 2019 | $15,000 | -25.0% | 5,000 | 0.0% | 0.01% | -22.2% |
Q2 2019 | $20,000 | -16.7% | 5,000 | -87.5% | 0.01% | -10.0% |
Q1 2019 | $24,000 | +118.2% | 40,064 | 0.0% | 0.01% | +100.0% |
Q4 2018 | $11,000 | -64.5% | 40,064 | 0.0% | 0.01% | -58.3% |
Q3 2018 | $31,000 | +82.4% | 40,064 | +101.1% | 0.01% | +71.4% |
Q2 2018 | $17,000 | -19.0% | 19,921 | 0.0% | 0.01% | -22.2% |
Q1 2018 | $21,000 | -93.8% | 19,921 | -93.2% | 0.01% | -93.2% |
Q4 2017 | $339,000 | -23.8% | 291,934 | -4.2% | 0.13% | -30.2% |
Q3 2017 | $445,000 | -72.0% | 304,886 | 0.0% | 0.19% | -72.2% |
Q2 2017 | $1,592,000 | -14.3% | 304,886 | 0.0% | 0.68% | -21.1% |
Q1 2017 | $1,857,000 | +47.9% | 304,886 | +0.0% | 0.86% | +33.2% |
Q4 2016 | $1,256,000 | +8.2% | 304,822 | +34.4% | 0.65% | +10.6% |
Q3 2016 | $1,161,000 | +24.8% | 226,822 | +0.0% | 0.59% | +6.9% |
Q2 2016 | $930,000 | -47.0% | 226,740 | 0.0% | 0.55% | -41.2% |
Q1 2016 | $1,755,000 | – | 226,740 | – | 0.93% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 25,000,000 | $19,500,000 | 0.84% |
Polaris Venture Management Co. V, L.L.C. | 1,968,606 | $1,535,000 | 0.77% |
Vivo Capital, LLC | 8,180,000 | $6,378,000 | 0.64% |
Ghost Tree Capital, LLC | 3,525,000 | $2,748,000 | 0.58% |
BVF INC/IL | 5,265,000 | $4,105,000 | 0.36% |
Birchview Capital, LP | 189,000 | $147,000 | 0.10% |
DRW Securities, LLC | 469,343 | $366,000 | 0.02% |
Fosun International Ltd | 403,678 | $323,000 | 0.02% |
Alyeska Investment Group, L.P. | 1,500,000 | $1,170,000 | 0.01% |
AlphaMark Advisors, LLC | 40,064 | $31,000 | 0.01% |